Literature DB >> 24963575

Ceritinib in ALK-rearranged non-small-cell lung cancer.

Alice T Shaw, Jeffrey A Engelman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24963575     DOI： 10.1056/NEJMc1404894

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  62 in total

Review 1.  Patterns of Chromosomal Aberrations in Solid Tumors.

Authors:  Marian Grade; Michael J Difilippantonio; Jordi Camps
Journal:  Recent Results Cancer Res       Date:  2015

2.  Proteolysis Targeting Chimeras (PROTACs) of Anaplastic Lymphoma Kinase (ALK).

Authors:  Chengwei Zhang; Xiao-Ran Han; Xiaobao Yang; Biao Jiang; Jing Liu; Yue Xiong; Jian Jin
Journal:  Eur J Med Chem       Date:  2018-03-27       Impact factor: 6.514

3.  Exceptional Responders Inspire Change: Lessons for Drug Development From the Bedside to the Bench and Back.

Authors:  Nicole G Chau; Jochen H Lorch
Journal:  Oncologist       Date:  2015-06-03

Review 4.  Drug-Induced Hypophosphatemia: Current Insights.

Authors:  Efstathia Megapanou; Matilda Florentin; Haralampos Milionis; Moses Elisaf; George Liamis
Journal:  Drug Saf       Date:  2020-03       Impact factor: 5.606

Review 5.  Lung adenocarcinoma: from molecular basis to genome-guided therapy and immunotherapy.

Authors:  Roberto Chalela; Víctor Curull; César Enríquez; Lara Pijuan; Beatriz Bellosillo; Joaquim Gea
Journal:  J Thorac Dis       Date:  2017-07       Impact factor: 2.895

6.  Lung Master Protocol (Lung-MAP)-A Biomarker-Driven Protocol for Accelerating Development of Therapies for Squamous Cell Lung Cancer: SWOG S1400.

Authors:  Roy S Herbst; David R Gandara; Fred R Hirsch; Mary W Redman; Michael LeBlanc; Philip C Mack; Lawrence H Schwartz; Everett Vokes; Suresh S Ramalingam; Jeffrey D Bradley; Dana Sparks; Yang Zhou; Crystal Miwa; Vincent A Miller; Roman Yelensky; Yali Li; Jeff D Allen; Ellen V Sigal; David Wholley; Caroline C Sigman; Gideon M Blumenthal; Shakun Malik; Gary J Kelloff; Jeffrey S Abrams; Charles D Blanke; Vassiliki A Papadimitrakopoulou
Journal:  Clin Cancer Res       Date:  2015-02-13       Impact factor: 12.531

7.  Targeting ALK With Crizotinib in Pediatric Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumor: A Children's Oncology Group Study.

Authors:  Yael P Mossé; Stephan D Voss; Megan S Lim; Delphine Rolland; Charles G Minard; Elizabeth Fox; Peter Adamson; Keith Wilner; Susan M Blaney; Brenda J Weigel
Journal:  J Clin Oncol       Date:  2017-08-08       Impact factor: 44.544

Review 8.  Lung cancer diagnosis and staging in the minimally invasive age with increasing demands for tissue analysis.

Authors:  Erik Folch; Daniel B Costa; Jeffrey Wright; Paul A VanderLaan
Journal:  Transl Lung Cancer Res       Date:  2015-08

Review 9.  Somatic Engineering of Oncogenic Chromosomal Rearrangements: A Perspective.

Authors:  Danilo Maddalo; Andrea Ventura
Journal:  Cancer Res       Date:  2016-08-12       Impact factor: 12.701

10.  Identification of a novel metabolic-related mutation (IDH1) in metastatic pancreatic cancer.

Authors:  Jonathan R Brody; Cinthya S Yabar; Mahsa Zarei; Joseph Bender; Lynn M Matrisian; Lola Rahib; Craig Heartwell; Kimberly Mason; Charles J Yeo; Stephen C Peiper; Wei Jiang; Katelyn Varieur; Subha Madhavan; Emanuel Petricoin; Danielle Fortuna; Mark Curtis; Zi-Xuan Wang; Michael J Pishvaian; Jordan M Winter
Journal:  Cancer Biol Ther       Date:  2018-03-06       Impact factor: 4.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.